{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:02:16Z","timestamp":1790726536903,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":237,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02742","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T15:02:43Z","timestamp":1788188563000},"page":"e02742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Combination therapy with cefiderocol and minocycline for Stenotrophomonas maltophilia bacteremia in an obese patient on maintenance hemodialysis: A case report"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7264-6226","authenticated-orcid":false,"given":"Kosuke","family":"Kameda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7102-215X","authenticated-orcid":false,"given":"Keisuke","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsue","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02742_bib1","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cmi.2025.04.031","article-title":"How do I manage a patient with Stenotrophomonas maltophilia infection?","volume":"31","author":"Monardo","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idcr.2026.e02742_bib2","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","volume":"79","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02742_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/antibiotics13060553","article-title":"Optimizing antibiotic therapy for Stenotrophomonas maltophilia infections in critically ill patients: A pharmacokinetic\/pharmacodynamic approach","volume":"13","author":"Barrasa","year":"2024","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.idcr.2026.e02742_bib4","unstructured":"Shionogi & Co., Ltd Fetroja (cefiderocol) 1 g for intravenous Infusion: Interview Form. 4th ed Revised November 2025 [in Japanese]."},{"key":"10.1016\/j.idcr.2026.e02742_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s40121-025-01117-2","article-title":"Cefiderocol for the treatment of nosocomial bloodstream infections caused by Stenotrophomonas maltophilia: A case series and literature review","volume":"14","author":"Vena","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.idcr.2026.e02742_bib6","article-title":"Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia","volume":"64","author":"Biagi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2026.e02742_bib7","first-page":"88","article-title":"Stenotrophomonas maltophilia infections in haematological malignancies and hematopoietic stem cell transplantation: A case series including cefiderocol-based regimens","volume":"60","author":"Lupia","year":"2024","journal-title":"Med (Kaunas)"},{"key":"10.1016\/j.idcr.2026.e02742_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jgar.2023.05.013","article-title":"First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen","volume":"34","author":"Medioli","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.idcr.2026.e02742_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106395","article-title":"Optimised cefiderocol exposures in a successfully treated critically ill patient with polymicrobial Stenotrophomonas maltophilia bacteraemia and pneumonia receiving continuous venovenous haemodiafiltration","volume":"58","author":"Fratoni","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idcr.2026.e02742_bib10","series-title":"CLSI supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2026"},{"key":"10.1016\/j.idcr.2026.e02742_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02742_bib12","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/jcm13082275","article-title":"Clinical outcomes of trimethoprim\/sulfamethoxazole in critically ill patients with Stenotrophomonas maltophilia bacteremia and pneumonia utilizing renal replacement therapies","volume":"13","author":"El Nekidy","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.idcr.2026.e02742_bib13","unstructured":"Taiyo Pharma Co., Ltd BACTRAMIN for Injection [package insert]. Tokyo, Japan: Taiyo Pharma Co., Ltd.; 2021 [in Japanese]."},{"key":"10.1016\/j.idcr.2026.e02742_bib14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/jac\/dkae168","article-title":"Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan","volume":"79","author":"Hase","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2026.e02742_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"MacGowan A. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2026.e02742_bib16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s40262-021-01063-5","article-title":"Clinical pharmacokinetics and pharmacodynamics of cefiderocol","volume":"60","author":"Bilal","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.idcr.2026.e02742_bib17","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/pharmaceutics14122786","article-title":"Total and unbound pharmacokinetics of cefiderocol in critically ill patients","volume":"14","author":"Zahr","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.idcr.2026.e02742_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40262-021-01086-y","article-title":"Pharmacokinetics, pharmacodynamics, and dose optimization of cefiderocol during continuous renal replacement therapy","volume":"61","author":"Wenzler","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.idcr.2026.e02742_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad174","article-title":"Successful treatment of persistent Stenotrophomonas maltophilia bacteremia with cefiderocol in an infant","volume":"10","author":"Hsu","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02742_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02031-18","article-title":"vivo pharmacodynamic study of cefiderocol, a novel parenteral siderophore cephalosporin, in murine thigh and lung infection models","volume":"63","author":"Nakamura","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:16:42Z","timestamp":1790723802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"alternative-id":["S2214250926002556"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02742","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy with cefiderocol and minocycline for Stenotrophomonas maltophilia bacteremia in an obese patient on maintenance hemodialysis: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02742"}}